Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes

This publication has 38 references indexed in Scilit:

• Molecular Cross-talk between the TRAIL and Interferon Signaling Pathways
  Journal of Biological Chemistry, 2002
• Complex immunomodulatory effects of interferon‐β in multiple sclerosis include the upregulation of T helper 1‐associated marker genes
  Annals of Neurology, 2001
• Genomic Organization and Transcriptional Regulation of Human Apo2/TRAIL Gene
  Biochemical and Biophysical Research Communications, 2000
• Comparative Analysis of CD137 and LPS Effects on Monocyte Activation, Survival, and Proliferation
  Biochemical and Biophysical Research Communications, 2000
• Safety and antitumor activity of recombinant soluble Apo2 ligand
  Journal of Clinical Investigation, 1999
• Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAIL
  The Journal of Experimental Medicine, 1999
• The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain
  Immunity, 1997
• Interleukin-1β Converting Enzyme–like Protease Involvement in Fas-induced and Activation-induced Peripheral Blood T Cell Apoptosis in HIV Infection. TNF-related Apoptosis-inducing Ligand Can Mediate Activation-induced T Cell Death in HIV Infection
  The Journal of Experimental Medicine, 1997
• Execution and suicide: cytotoxic lymphocytes enforce Draconian laws through separate molecular pathways
  Current Opinion in Immunology, 1995
• SELECTIVE TRIGGERING OF HUMAN T AND B LYMPHOCYTES IN VITRO BY POLYCLONAL MITOGENS
  The Journal of Experimental Medicine, 1974